Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Targeting specific T cells may help treat alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.